Ethical Overkill: Institutions should take a unified look at protections for research on human subjects
By Editorial,
Nature
| 12. 09. 2014
The most important resource needed to conduct research on humans, it is said, is not brainpower or money: it is trust. In the United States, as elsewhere, hundreds of institutions and thousands of investigators work to protect that trust by carefully evaluating proposals for clinical trials and other research that uses human subjects.
Each US institution hosting such a study typically conducts its own ethical review of the proposal. The review process serves many functions: it is an expression of the responsibility that these investigators feel towards protecting their local community, an opportunity to tweak protocols to adapt to the community’s specific needs, and a protection against potential lawsuits resulting from a flawed research protocol.
Sadly, evidence suggests that much of this effort is misplaced. A 2010 survey of 45 institutions reviewing the same protocol found that local scrutiny resulted in no substantial changes (B. Ravina et al. Ann. Neurol. 67, 258–260; 2010). Instead, most alterations simply inserted standardized institutional language — unrelated to the proposed study — to the informed-consent document signed by research participants before they...
Related Articles
By Nahlah Ayed, CBC Listen | 10.22.2025
Egg freezing is one of today’s fastest-growing reproductive technologies. It's seen as a kind of 'fertility insurance' for the future, but that doesn’t address today’s deeper feelings of uncertainty around parenthood, heterosexual relationships, and the reproductive path forward. In this...
By Emile Torres, Jacobin | 11.15.2025
Watching tech moguls throw caution to the wind in the AI arms race or equivocate on whether humanity ought to continue, it’s natural to wonder whether they care about human lives.
The earnest, in-depth answer to this question is just...
By [cites CGS' Katie Hasson], KCBS Radio | 11.19.2025
This is Ask An Expert, where every weekday at 9:20am, KCBS Radio is giving you direct access to top experts in various fields. Today: Gene-editing technology allows scientists to work with DNA in unprecedented ways, but there are larger scientific...
By Antonio Regalado, MIT Technology Review | 10.31.2025
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology.
The new company, called Preventive, is...